Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in Metastatic Osteosarcoma
NCT01759303Phase 2Terminated
- Sponsor
- Emerald Clinical
- Start
- Apr 2013
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in osteosarcoma (OS), sponsored by Emerald Clinical. Started Apr 2013; status: terminated.
02
Drugs
pazopanib
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT01759303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01759303.